Key facts
- Intron Health’s last known valuation is $10.0M (Oct 2023).
- It has raised $1.5M; the latest was Later Stage VC in Sep 2025.
- Notable investors include Plug and Play Tech Center, Impact Assets, Octopus Ventures, BakerBridge Capital, Africa Health Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Intron Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Intron Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Intron Health
Developer of speech-to-text software intended for voice interactions across Africa. The company's software powers voice applications, including clinical ambient listening, medical dictation, judicial and legislative transcription, voice commands for mobile application interaction, reproductive health voice bots, call center inbound and outbound automation, meeting minutes and voice authentication, enabling healthcare professionals to reduce manual documentation.
- Sector
- Healthcare
- HQ
- Lagos, Nigeria
- Founded
- 2020
- Employees
- 35
- Website
- intron.io/
- Ownership
- Privately Held (backing)
Intron Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Intron Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Intron Health in its N-PORT filings yet. We sweep new filings monthly.